Genus plc 2.8% Potential Upside Indicated by HSBC

Broker Ratings

Genus plc using EPIC/TICKER code (LON:GNS) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ today by analysts at HSBC. Genus plc are listed in the Health Care sector within UK Main Market. HSBC have set a target price of 3260 GBX on its stock. This would imply the analyst believes there is now a potential upside of 2.8% from the opening price of 3170.08 GBX. Over the last 30 and 90 trading days the company share price has increased 130.08 points and increased 646.08 points respectively. The 52 week high share price is 3170.08 GBX while the 52 week low for the share price is 2090 GBX.

Genus plc has a 50 day moving average of 2,942.51 GBX and a 200 Day Moving Average share price is recorded at 2,621.41. There are currently 65,070,463 shares in issue with the average daily volume traded being 93,212. Market capitalisation for LON:GNS is £2,018,485,762 GBP.

Share on:
Find more news, interviews, share price & company profile here for:

    Genus Plc expects to report profits ahead of expectations

    Genus Plc (LON: GNS) announces robust H1 FY25 results, projecting a pre-tax profit of £35m, surpassing expectations despite currency headwinds.

    Genus plc profit performance lower with adjusted PBT decreasing 26%

    Genus plc (LON:GNS) announces interim results for 6 months ended 31 Dec 2023. Resilient revenue amidst challenges; profit lower year on year.

      Search

      Search